Cart
sales@molnova.com
DSP-2230
CAS No. 1233231-30-5
DSP-2230( —— )
Catalog No. M23409 CAS No. 1233231-30-5
DSP-2230 is a selective blocker of Nav1.7/Nav1.8.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 230 | In Stock |
|
| 50MG | 425 | In Stock |
|
| 100MG | 624 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDSP-2230
-
NoteResearch use only, not for human use.
-
Brief DescriptionDSP-2230 is a selective blocker of Nav1.7/Nav1.8.
-
DescriptionDSP-2230 is a selective blocker of Nav1.7/Nav1.8.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorNav1.7 channel|Nav1.8 channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1233231-30-5
-
Formula Weight419.4
-
Molecular FormulaC20H20F3N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (298.04 mM; Need ultrasonic)
-
SMILESC[C@H](C(N)=O)NCc(n1C2CCC2)nc(cc2)c1nc2Oc(cc1F)cc(F)c1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bagal SK, et al. Voltage gated sodium channels as drug discovery targets. Channels (Austin). 2015;9(6):360-6.
molnova catalog
related products
-
Lacosamide
An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.
-
AZD-1305
AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of Ikr.
-
Nefopam hydrochlorid...
Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.
